Co-Authors
This is a "connection" page, showing publications co-authored by Franck Touret and Jean-Sélim Driouich.
Connection Strength
0.711
-
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Res. 2021 09; 193:105137.
Score: 0.239
-
Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium. mBio. 2021 08 31; 12(4):e0085021.
Score: 0.239
-
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021 03 19; 12(1):1735.
Score: 0.234